ACADIA Pharmaceuticals IncNASDAQ:ACAD
- LAST PRICE15.3800
- TODAY'S CHANGE (%)-0.3100 (-1.9758%)
- Bid / Lots15.3400/ 5
- Ask / Lots15.4400/ 2
- Open / Previous Close15.6000 / 15.6900
- Day Range
- 52 Week Range
- Volume1,959,991
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACAD |
|---|---|---|
| 09:32 ET | 7442 | 15.6 |
| 09:41 ET | 200 | 15.72 |
| 09:43 ET | 2323 | 15.71 |
| 09:45 ET | 1100 | 15.685 |
| 09:48 ET | 1238 | 15.71 |
| 09:50 ET | 882 | 15.7355 |
| 09:52 ET | 300 | 15.71 |
| 09:54 ET | 5487 | 15.74 |
| 09:56 ET | 2909 | 15.73 |
| 09:57 ET | 5250 | 15.725 |
| 09:59 ET | 6074 | 15.7599 |
| 10:01 ET | 1700 | 15.8 |
| 10:03 ET | 2199 | 15.82 |
| 10:06 ET | 2903 | 15.83 |
| 10:08 ET | 901 | 15.82 |
| 10:10 ET | 17881 | 15.7795 |
| 10:12 ET | 2115 | 15.71 |
| 10:14 ET | 15383 | 15.715 |
| 10:15 ET | 2291 | 15.735 |
| 10:17 ET | 2034 | 15.73 |
| 10:19 ET | 3343 | 15.67 |
| 10:21 ET | 2300 | 15.675 |
| 10:24 ET | 1275 | 15.68 |
| 10:26 ET | 3614 | 15.63 |
| 10:28 ET | 1770 | 15.64 |
| 10:30 ET | 2141 | 15.63 |
| 10:32 ET | 600 | 15.66 |
| 10:33 ET | 2837 | 15.66 |
| 10:35 ET | 5667 | 15.655 |
| 10:37 ET | 1836 | 15.64 |
| 10:39 ET | 2535 | 15.64 |
| 10:42 ET | 327 | 15.635 |
| 10:44 ET | 2604 | 15.66 |
| 10:46 ET | 1707 | 15.665 |
| 10:48 ET | 755 | 15.66 |
| 10:50 ET | 500 | 15.65 |
| 10:51 ET | 1782 | 15.615 |
| 10:53 ET | 302 | 15.6075 |
| 10:55 ET | 400 | 15.6 |
| 10:57 ET | 3971 | 15.595 |
| 11:00 ET | 600 | 15.59 |
| 11:02 ET | 1683 | 15.57 |
| 11:04 ET | 300 | 15.58 |
| 11:06 ET | 1100 | 15.59 |
| 11:08 ET | 849 | 15.58 |
| 11:09 ET | 700 | 15.565 |
| 11:11 ET | 1302 | 15.55 |
| 11:13 ET | 1666 | 15.55 |
| 11:15 ET | 500 | 15.57 |
| 11:18 ET | 1253 | 15.57 |
| 11:20 ET | 1325 | 15.57 |
| 11:22 ET | 1150 | 15.57 |
| 11:24 ET | 983 | 15.55 |
| 11:26 ET | 1100 | 15.54 |
| 11:27 ET | 1779 | 15.5475 |
| 11:29 ET | 2207 | 15.545 |
| 11:31 ET | 400 | 15.54 |
| 11:33 ET | 100 | 15.535 |
| 11:36 ET | 4771 | 15.51 |
| 11:38 ET | 423 | 15.51 |
| 11:40 ET | 2364 | 15.5 |
| 11:42 ET | 600 | 15.51 |
| 11:44 ET | 9639 | 15.485 |
| 11:45 ET | 2134 | 15.5 |
| 11:47 ET | 1772 | 15.49 |
| 11:49 ET | 209 | 15.495 |
| 11:51 ET | 2514 | 15.485 |
| 11:54 ET | 813 | 15.48 |
| 11:56 ET | 200 | 15.47 |
| 11:58 ET | 2795 | 15.48 |
| 12:00 ET | 800 | 15.45 |
| 12:02 ET | 5133 | 15.42 |
| 12:03 ET | 23253 | 15.405 |
| 12:05 ET | 14991 | 15.4 |
| 12:07 ET | 12022 | 15.38 |
| 12:09 ET | 30553 | 15.395 |
| 12:12 ET | 12123 | 15.4 |
| 12:14 ET | 1946 | 15.38 |
| 12:16 ET | 4659 | 15.395 |
| 12:18 ET | 4762 | 15.39 |
| 12:20 ET | 7179 | 15.4 |
| 12:21 ET | 1225 | 15.38 |
| 12:23 ET | 7576 | 15.42 |
| 12:25 ET | 5111 | 15.44 |
| 12:27 ET | 3643 | 15.445 |
| 12:30 ET | 600 | 15.445 |
| 12:32 ET | 5276 | 15.47 |
| 12:34 ET | 2275 | 15.466622 |
| 12:36 ET | 4545 | 15.435 |
| 12:38 ET | 5624 | 15.425 |
| 12:39 ET | 6334 | 15.4 |
| 12:41 ET | 16392 | 15.445 |
| 12:43 ET | 23322 | 15.45 |
| 12:45 ET | 13378 | 15.46 |
| 12:48 ET | 2277 | 15.455 |
| 12:50 ET | 8019 | 15.465 |
| 12:52 ET | 1412 | 15.46 |
| 12:54 ET | 3759 | 15.455 |
| 12:56 ET | 11218 | 15.47 |
| 12:57 ET | 3469 | 15.515 |
| 12:59 ET | 1788 | 15.52 |
| 01:01 ET | 4884 | 15.505 |
| 01:03 ET | 1567 | 15.46 |
| 01:06 ET | 3346 | 15.475 |
| 01:08 ET | 6898 | 15.5 |
| 01:10 ET | 1162 | 15.49 |
| 01:12 ET | 7166 | 15.49 |
| 01:14 ET | 1920 | 15.5 |
| 01:15 ET | 7609 | 15.4988 |
| 01:17 ET | 4073 | 15.4808 |
| 01:19 ET | 3240 | 15.495 |
| 01:21 ET | 2245 | 15.505 |
| 01:24 ET | 4626 | 15.5 |
| 01:26 ET | 1862 | 15.48 |
| 01:28 ET | 306 | 15.48 |
| 01:30 ET | 2629 | 15.465 |
| 01:32 ET | 2674 | 15.465 |
| 01:33 ET | 100 | 15.465 |
| 01:35 ET | 480 | 15.465 |
| 01:37 ET | 3305 | 15.46 |
| 01:39 ET | 409 | 15.45 |
| 01:42 ET | 4224 | 15.465 |
| 01:44 ET | 2092 | 15.485 |
| 01:46 ET | 2000 | 15.495 |
| 01:48 ET | 1200 | 15.495 |
| 01:50 ET | 2461 | 15.495 |
| 01:51 ET | 272 | 15.495 |
| 01:53 ET | 6379 | 15.5 |
| 01:55 ET | 3224 | 15.495 |
| 01:57 ET | 4370 | 15.48 |
| 02:00 ET | 4630 | 15.5 |
| 02:02 ET | 200 | 15.495 |
| 02:04 ET | 5425 | 15.45 |
| 02:06 ET | 10312 | 15.45 |
| 02:08 ET | 9177 | 15.46 |
| 02:09 ET | 4472 | 15.46 |
| 02:11 ET | 500 | 15.46 |
| 02:13 ET | 10486 | 15.42 |
| 02:15 ET | 11174 | 15.38 |
| 02:18 ET | 4917 | 15.385 |
| 02:20 ET | 3651 | 15.38 |
| 02:22 ET | 3850 | 15.36 |
| 02:24 ET | 6205 | 15.34 |
| 02:26 ET | 13482 | 15.35 |
| 02:27 ET | 6416 | 15.39 |
| 02:29 ET | 4258 | 15.405 |
| 02:31 ET | 8254 | 15.35 |
| 02:33 ET | 3968 | 15.35 |
| 02:36 ET | 8723 | 15.355 |
| 02:38 ET | 4653 | 15.38 |
| 02:40 ET | 3944 | 15.375 |
| 02:42 ET | 5089 | 15.375 |
| 02:44 ET | 4945 | 15.36 |
| 02:45 ET | 4265 | 15.375 |
| 02:47 ET | 3400 | 15.385 |
| 02:49 ET | 1506 | 15.405 |
| 02:51 ET | 5153 | 15.385 |
| 02:54 ET | 2426 | 15.37 |
| 02:56 ET | 1165 | 15.36 |
| 02:58 ET | 7505 | 15.37 |
| 03:00 ET | 900 | 15.375 |
| 03:02 ET | 7067 | 15.335 |
| 03:03 ET | 3233 | 15.35 |
| 03:05 ET | 2746 | 15.345 |
| 03:07 ET | 1800 | 15.35 |
| 03:09 ET | 5330 | 15.365 |
| 03:12 ET | 6572 | 15.35 |
| 03:14 ET | 5994 | 15.31 |
| 03:16 ET | 2901 | 15.305 |
| 03:18 ET | 2271 | 15.31 |
| 03:20 ET | 6940 | 15.325 |
| 03:21 ET | 8869 | 15.33 |
| 03:23 ET | 6944 | 15.35 |
| 03:25 ET | 1986 | 15.35 |
| 03:27 ET | 4474 | 15.335 |
| 03:30 ET | 2105 | 15.31 |
| 03:32 ET | 6618 | 15.311 |
| 03:34 ET | 3200 | 15.315 |
| 03:36 ET | 7899 | 15.305 |
| 03:38 ET | 2258 | 15.305 |
| 03:39 ET | 800 | 15.305 |
| 03:41 ET | 7481 | 15.301 |
| 03:43 ET | 10367 | 15.295 |
| 03:45 ET | 13787 | 15.295 |
| 03:48 ET | 12024 | 15.305 |
| 03:50 ET | 20486 | 15.345 |
| 03:52 ET | 6517 | 15.35 |
| 03:54 ET | 8020 | 15.37 |
| 03:56 ET | 15541 | 15.34 |
| 03:57 ET | 26252 | 15.3875 |
| 03:59 ET | 451642 | 15.38 |
Sep 26, 2024
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Thursday Sep 26, 2024 by Dow Jones
4:05PM ET on Thursday Sep 26, 2024 by Dow Jones
Sep 23, 2024
*DJ Acadia Pharmaceuticals: Catherine Owen Adams Succeeds Steve Davis as CEO >ACAD, from 4:16PM ET on Monday Sep 23, 2024 by Dow Jones
4:16PM ET on Monday Sep 23, 2024 by Dow JonesCatherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals, from 4:15PM ET on Monday Sep 23, 2024 by Dow Jones
4:15PM ET on Monday Sep 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.7B | 84.8x | --- |
Azenta Inc | 2.4B | -17.2x | --- |
PTC Therapeutics Inc | 2.6B | -5.9x | --- |
Guardant Health Inc | 3.3B | -5.6x | --- |
Novavax Inc | 2.2B | -4.6x | --- |
Genmab A/S | 17.4B | 19.4x | +22.71% |
Company Information
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Contact Information
- Headquarters
- 12830 El Camino Real, Suite 400SAN DIEGO, CA, United States 92130
- Phone
- 858-558-2871
- Fax
- 858-558-2872
Executives
- Independent Chairman of the Board
- Stephen Biggar
- Chief Executive Officer, Director
- Catherine Owen Adams
- Chief Financial Officer, Executive Vice President
- Mark Schneyer
- Chief Operating Officer, Executive Vice President, Head of Commercial
- Brendan Teehan
- Executive Vice President, Company Secretary and Chief Legal Officer
- Jennifer Rhodes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
|---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 84.8x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 64.4x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
